Tech limitations promote tumor growth perception
Technological limitations, not biology, could be the cause of perceived high rates of breast tumor growth in younger women.
Technological limitations, not biology, could be the cause of perceived high rates of breast tumor growth in younger women. Previously, poor mammography screening outcomes for women aged 40 to 49 were pinned on faster tumor growth and reduced tumor detectability, but a new study shows the latter is the major culprit.
A breast cancer screening computer simulation model was developed for the study to estimate how biology and technology affect mammography sensitivity. The researchers calibrated the predicted breast cancer incidence rates to the actual rates from the Surveillance, Epidemiology, and End Results database. They compared distributions of screen-detected tumor sizes to the actual distributions obtained from the Breast Cancer Surveillance Consortium to estimate relative impact of lower tumor detectability and tumor volume doubling time on the younger women's screening outcomes.
The lowered ability to detect tumors accounted for 79% of the poorer sensitivity in the model, according to the research, which was published in the Journal of the National Cancer Institute. The remaining 21% was due to faster tumor growth (doi:10.1093/jnci/djq271).
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
